Table 3.
WGA method | Cell types | Number of tested SNP sites | Number of detected SNP sitesa | ADO in detected SNP sites | ADO rateb (%) |
---|---|---|---|---|---|
MALBAC | 1 cell (fibroblast) | 112 | 96 (85.71%) | 6 | 6.25 |
2 cells (fibroblasts) | 112 | 91 (81.25%) | 3 | 3.30 | |
5 cells (fibroblasts) | 112 | 109 (97.32%) | 1 | 0.92 | |
MDA | 1 cell (fibroblast) | 112 | 108 (97.62%) | 10 | 9.26 |
2 cells (fibroblasts) | 112 | 104 (92.86%) | 9 | 8.65 | |
5 cells (fibroblasts) | 112 | 112 (100.00%) | 0 | 0.00 |
SNP amplification efficiencies between the MALBAC and MDA methods for single‐cell groups: χ 2=7.906, P=.004; two‐cell groups; χ 2=6.694, P=.010; and five‐cell groups: χ 2=3.041, P=.081. The ADO rates in each cell‐type group did not differ significantly.
Significance (P value) evaluation between the MALBAC and MDA groups: aTotal SNP amplification rate; bThe total ADO rate. Chi‐square test (SPSS software, Chicago, IL, USA) data: a χ 2=16.341, P=.000; b χ 2=2.144, P=.143.